Detection of unsuspected bone metastases by 68Ga-DOTA: Nuclear medicine at the forefront again

Nuclear Medicine Communications

Volumn 32, Issue 10, 2011, Pages 877-879

  Al Nahhas, Adil ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; GALLIUM 68; IODINE 131; TECHNETIUM 99M;

BONE BIOPSY; BONE METASTASIS; BONE RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EDITORIAL; FOLLOW UP; HALF LIFE TIME; HUMAN; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; NEOPLASM MICROMETASTASIS; NUCLEAR MEDICINE;

EID: 80052458947     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834ad802     Document Type: Editorial

References (8)

1. Fleming WH, Mcilraith JD, King ER. Photoscanning of bone lesions utilizing Strontium-85. Radiology 1961; 77:635-636.
2. Charkes ND, Sklaroff DM. Early diagnosis of metastatic bone cancer by photoscanning with Strontium-85. J Nucl Med 1964; 5:168-179.
3. Hofmann M, Maecke H, Börner R, Weckesser E, Schöffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001; 28:1751-1757.
4. Al-Nahhas A, Win Z, Szyszko T, Singh A, Nanni C, Fanti S, Rubello D. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res 2007; 27 (6B):4087-4094.
5. Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, et al. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 2010; 252:850-856.
6. Putzer D, Gabriel M, Henninger B, Kendler D, Uprimny C, Dobrozemsky G, et al. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTATyr3- octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med 2009; 50:1214-1221.
7. Ambrosini V, Nanni C, Zompatori M, Campana D, Tomassetti P, Castellucci P, et al. (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2010; 37:722-727.
8. 68Ga-DOTATATE PET with co-registered low dose CT in the detection of bone metastases in patients with neuroendocrine tumours. Nucl Med Commun 2011; 32:426(abst).